Related Experiment Videos
Suppression of mitogen-induced lymphocyte proliferation by syringomycin-E
1Immunology Laboratory, MSRB-I, University of Michigan, Ann Arbor 48109-0656, USA.
FEMS Immunology and Medical Microbiology
|September 1, 1996
Summary
Syringomycin E (SR-E), a bacterial compound, was investigated for its impact on human lymphocyte proliferation. This study found that SR-E significantly suppresses mitogen-induced lymphocyte proliferation, suggesting potential immunosuppressive properties.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Syringomycin E (SR-E) is a bacterial lipodepsipeptide known for antifungal properties.
- Other lipodepsipeptides like cyclosporine exhibit immunosuppressive activities.
Purpose of the Study:
- To investigate the effect of Syringomycin E (SR-E) on human blood lymphocyte proliferation in vitro.
- To determine if SR-E possesses immunosuppressive properties similar to other known compounds.
Main Methods:
- In vitro study of human blood lymphocytes.
- Assay of lymphocyte proliferation induced by various mitogens: pokeweed mitogen (PWM), phytohemagglutinin (PHA), and anti-CD3 monoclonal antibody.
- Evaluation of SR-E's effect on proliferation, both alone and in the presence of mitogens.
Main Results:
- SR-E alone did not affect lymphocyte proliferation.
- SR-E significantly suppressed mitogen-induced lymphocyte proliferation.
- The suppressive effect was most pronounced with PWM compared to PHA or anti-CD3.
Conclusions:
- SR-E demonstrates significant immunosuppressive activity on T cell-dependent immune responses.
- SR-E shows potential as a novel immunosuppressive compound for therapeutic applications.